NICM HRI: The quest for novel therapeutic agents for pancreatic cancer

Event Name
NICM HRI: The quest for novel therapeutic agents for pancreatic cancer
19 August 2021
12:00 pm - 01:00 pm

Address (Room): Zoom webinar


NICM Health Research Institute presents Professor Christopher Scarlett, School of Environmental and Life Sciences, University of Newcastle. Join guest seminar speaker, Professor Scarlett on 19 August, as he discusses novel therapeutic approaches in the treatment of pancreatic cancer. ABSTRACT Pancreatic cancer is a devastating disease with an abysmal survival rate of approximately 10% at five years. In Australia there were 3,900 new cases and 3,300 deaths in 2020. Current therapies are palliative at best highlighting the urgent need for novel therapeutic agents targeting molecular phenotypes not responsive to current treatments. The highly heterogeneic and metastatic nature of pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer, presents a major challenge in therapeutic development. Professor Scarlett, along with the Pancreatic Cancer Research Group he leads, are searching on land, at sea, and within the laboratory for potential therapeutic agents targeting molecular mechanisms that contribute to these aggressive, metastatic subtypes. WHEN: Thursday 19 August 2021 TIME: 12.00pm - 1.00pm AEST VENUE: Zoom webinar COST: Free and open to all RSVP: Register by visiting

Speakers: Professor Christopher Scarlett, University of Newcastle

Web page:

Name: Jennifer Rodda

Phone: 0417 296 203

School / Department: NICM Health Research Institute